Clinical Trials
32
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (17 trials with phase data)• Click on a phase to view related trials
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions (BIOFLOW-48) Study
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2025-01-16
- Last Posted Date
- 2025-01-17
- Lead Sponsor
- Biotronik, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT06779630
BIOTRONIK Conduction System Pacing With the Solia Lead - Solia CSP S
- Conditions
- Sinus Node DysfunctionBradycardiaAtrioventricular Block
- First Posted Date
- 2024-08-06
- Last Posted Date
- 2025-05-31
- Lead Sponsor
- Biotronik, Inc.
- Target Recruit Count
- 110
- Registration Number
- NCT06540079
- Locations
- 🇺🇸
Banner - University Medical Center Phoenix, Phoenix, Arizona, United States
🇺🇸Cardiology Associates Medical Group, Ventura, California, United States
🇺🇸Sarasota Memorial Hospital, Sarasota, Florida, United States
BIOTRONIK Conduction System Pacing With the Solia Lead
- Conditions
- BradycardiaAtrioventricular BlockLeft Bundle-Branch BlockCardiomyopathies
- First Posted Date
- 2022-02-22
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- Biotronik, Inc.
- Target Recruit Count
- 194
- Registration Number
- NCT05251363
- Locations
- 🇺🇸
Banner - University Medical Center Phoenix, Phoenix, Arizona, United States
🇺🇸Cardiology Associates Medical Group, Ventura, California, United States
🇺🇸Washington Hospital Center, Washington, District of Columbia, United States
Atrial Fibrillation Associated With Heart Failure Treated by BIOTRONIK's CRT-DX System
- Conditions
- Heart FailureAtrial FibrillationCardiac Resynchronization Therapy
- First Posted Date
- 2021-05-03
- Last Posted Date
- 2022-01-28
- Lead Sponsor
- Biotronik, Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT04870281
- Locations
- 🇺🇸
University of California San Diego - La Jolla, La Jolla, California, United States
🇺🇸Cardiology Associates Medical Group, Ventura, California, United States
🇺🇸Orlando Health Heart Institute, Orlando, Florida, United States
A First in Human Feasibility Study to Evaluate the Safety and Effectiveness of the BIOTRONIK Prospera SCS System with HomeStream Remote Management
- Conditions
- Chronic Leg PainChronic Low-back Pain
- First Posted Date
- 2020-12-24
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- Biotronik, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT04683718
- Locations
- 🇦🇺
Genesis Research Services, Broadmeadow, New South Wales, Australia
🇦🇺Australian Medical Research, Hurstville, New South Wales, Australia
🇦🇺Sydney Pain Research Centre, Wahroonga, New South Wales, Australia
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next